For the treatment of proven dapsone-resistant leprosy, Lamprene (clofazimine)  should be given at a dosage of 100 mg daily in combination with one or more other antileprosy drugs for 3 years, followed by monotherapy with 100 mg of Lamprene (clofazimine)  daily.